CLINICAL_TRIALS
trial_result
· 2019-06-05
Clinical Trial Update: Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102) [Phase 2]
Summary
Phase 2 clinical trial of anlotinib in esophageal squamous cell carcinoma completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED